Aslani, Rina H.

HRN: 13-46-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/07/2022
MEBENDAZOLE 100MG/5ML, 60ML SUSPENSION
12/07/2022
12/09/2022
PO
5 Ml
BID
Ascariasis
Waiting Final Action 
12/07/2022
CEFUROXIME 750MG (VIAL)
12/07/2022
12/13/2022
IVT
300 Mg
Q8h
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: